JASMINE SAVOIE: Open Payments
NPI 1205517638 · MAMOU, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 21 payments from 12 companies in 2025. Trend: 2023 $246 · 2024 $571 · 2025 $514
Food & beverage: $415Education: $99
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $185 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Stemline Therapeutics Inc. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $41 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| BeOne Medicines USA, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
Products named: Enhertu, KISQALI, Orserdu, DATROWAY, KEYTRUDA, Padcev, BRUKINSA, JEMPERLI.
Industry payments across LA — which companies pay providers there.
